Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
暂无分享,去创建一个
Martin A. Nowak | Robert A. Colbert | Sarah Rowland-Jones | Andrew J. McMichael | M. Nowak | S. Rowland-Jones | R. Phillips | P. Goulder | G. Ogg | A. McMichael | A. Edwards | P. Giangrande | R. Colbert | Rodney E. Phillips | Graham Ogg | Philip J.R. Goulder | Graz Luzzi | Anne Edwards | Paul Giangrande | G. Luzzi | Stephen McAdam | Barbara Morgana | S. Mcadam | Barbara Morgana | S. McAdam | R. Phillips
[1] R. Phillips,et al. Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef. , 1997, AIDS.
[2] Carol Carter,et al. Crystal structure of dimeric HIV-1 capsid protein , 1996, Nature Structural Biology.
[3] J. Levy,et al. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.
[4] B. Walker,et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. , 1996, Journal of immunology.
[5] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[6] A. McNeil,et al. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. , 1996, QJM : monthly journal of the Association of Physicians.
[7] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[8] C. Rinaldo,et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.
[9] T. Braciale,et al. Why can't cytotoxic T cells handle HIV? , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Rowland-Jones,et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[12] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[13] A. Meyerhans,et al. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. , 1995, Journal of immunology.
[14] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[15] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[16] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[17] J. Levy,et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein , 1994, The Journal of experimental medicine.
[18] Persephone Borrow,et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV , 1994, Nature.
[19] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[20] Sarah Rowland-Jones,et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.
[21] S. Rowland-Jones,et al. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. , 1994, Immunity.
[22] X. Jin,et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.
[23] R. F. Smith,et al. Human retroviruses and aids, 1992 , 1992 .
[24] Dean R. Madden,et al. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.
[25] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[26] A. Meyerhans,et al. In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity , 1991, European journal of immunology.
[27] D. R. Madden,et al. Identification of self peptides bound to purified HLA-B27 , 1991, Nature.
[28] Timothy E. Elliott,et al. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules , 1991, European journal of immunology.
[29] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[30] Gilcher Ro. Human retroviruses and AIDS. , 1988 .